Zhong JL
ORCID: 0000-0001-8997-6824
· 1 paper in corpus
BackgroundDespite therapeutic advancements (e.g. B-RAF inhibitors) targeting cutaneous melanoma, many cellular processes, including inducible heme oxygenase 1 (HO-1), counteract treatments for malignancies. So there is an urgent need to fin…